Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor-bone cellular interactions in skeletal metastases.

J M Chirgwin1, K S Mohammad, T A Guise

  • 1Division of Endocrinology, Department of Medicine, University of Virginia, Charlottesville, VA 22908, USA. jc3qb@virginia.edu

Journal of Musculoskeletal & Neuronal Interactions
|December 24, 2004
PubMed
Summary

Animal models reveal how tumor cells cause bone metastases by creating a vicious cycle with bone cells. Identifying secreted factors offers new therapeutic targets to disrupt this process.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations.

Journal of bone oncology·2021
Same author

Suppression of cancer-associated bone loss through dynamic mechanical loading.

Bone·2021
Same author

Elevated incidence of fractures in women with invasive breast cancer.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2015
Same author

Blocking the ZZ domain of sequestosome1/p62 suppresses myeloma growth and osteoclast formation in vitro and induces dramatic bone formation in myeloma-bearing bones in vivo.

Leukemia·2015
Same author

Cancer treatment-induced bone loss in premenopausal women: a need for therapeutic intervention?

Cancer treatment reviews·2012
Same author

Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer.

Oncogene·2011

Area of Science:

  • Oncology
  • Skeletal Biology
  • Cancer Metastasis

Background:

  • Bone metastases are a significant clinical challenge, often involving complex interactions between tumor and bone cells.
  • Animal models using immunocompromised mice and human tumor cells reliably replicate bone metastasis features seen in patients.
  • These models allow for the identification of critical tumor- and bone-derived factors driving skeletal metastasis.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying the vicious cycle in bone metastasis.
  • To identify key secreted factors mediating tumor-bone interactions.
  • To explore potential therapeutic targets for managing bone metastases.

Main Methods:

  • Inoculation of human tumor cells into the arterial circulation of immunocompromised mice to establish bone metastases.

Related Experiment Videos

  • Analysis of tumor-produced and bone-derived factors involved in metastasis.
  • Review of existing and investigational therapeutic strategies targeting bone metastasis.

    • Main Results:

    • Bone metastases can be osteolytic or osteoblastic, driven by specific factors like parathyroid hormone-related protein (PTHrP) and endothelin-1 (ET-1).
    • A reciprocal signaling loop exists where bone factors (e.g., IGFs, TGF-β) also stimulate tumor growth.
    • Therapeutic strategies targeting these factors, such as bisphosphonates and PTHrP-neutralizing antibodies, are under investigation.

    Conclusions:

    • The interplay between tumor and bone cells, mediated by secreted factors, perpetuates skeletal metastases.
    • Targeting these specific molecular interactions offers promising avenues for novel adjuvant therapies.
    • Further research into newly identified factors may yield future clinical applications for bone metastasis treatment.